Fragility fractures are a serious complication of type 1 and type 2 diabetes, but many clinicians who treat patients with diabetes are not aware of the increased risk of these fractures.
Fragility fractures are a serious complication of type 1 and type 2 diabetes, but many clinicians who treat patients with diabetes are not aware of the increased risk of these fractures. A new review, published by the International Osteoporosis Foundation Bone and Diabetes Working Group, summarized research and outlined an algorithm for identifying and managing diabetic patients with their increased fractured risk.
The review considered clinical characteristics of bone fragility in adults with diabetes and included findings from recent studies that assessed bone mineral density (BMD), bone microstructure and material properties, biochemical markers, and fracture prediction algorithms (FRAX) in patients with diabetes. Also, the authors evaluated the impact of diabetes drugs on bones, in addition to the efficacy of osteoporosis treatments in this population.
"The link between diabetes and skeletal health is complex and the optimal approach to the management of bone health in patients with diabetes is not yet definitive and may change over time as findings of new clinical studies become available,” Serge Ferrari, MD, chair of the International Osteoporosis Foundation (IOF) Committee of Scientific Advisors and of the IOF Bone and Diabetes Working Group, said in a statement.
The main messages of the review included:
“This new review will inform clinicians about the current state of knowledge, and, importantly, the clear algorithm will facilitate the clinical assessment and management of fragility fracture risk in their patients according to current best practice," Ferrari said.
The authors suggested the need for future studies in order to continue the evaluation of the structural determinants of bone fragility and to refine fracture prediction algorithms by including disease-specific determinants of fracture. Specifically, they suggested that new trials must prospectively investigate the efficacy and safety of osteoporosis treatments in those with diabetes with and without low BMD.
Furthermore, the researchers noted that this type of algorithm, that the review outlines, represents a consensus among some experts and will adapt overtime as more evidence is found.
Reference
Ferrari SL, Abrahamsen B, Napoli N, et al. Diagnosis and management of bone fragility in diabetes: an emerging challenge. [published online July 31, 2018]. Osteoporos Int. doi: 10.1007/s00198-018-4650-2.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen